PTC Therapeutics | PTCT - Equity Capital And Reserves

Stock Price
67.95
Daily Change
-1.03 -1.49%
Monthly
-10.86%
Yearly
33.34%
Q1 Forecast
68.47

PTC Therapeutics reported $-205.31M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 917.27M 94.89M Sep/2025
Alnylam Pharmaceuticals USD 789.18M 555.28M Dec/2025
Amgen USD 8.66B 961M Dec/2025
BioCryst Pharmaceuticals USD -387.89M 33.7M Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
BioMarin Pharmaceutical USD 6.09B 30.29M Dec/2025
Cytokinetics USD -659.62M 138.5M Dec/2025
Daiichi Sankyo JPY 1.71T 57.86B Dec/2025
Enanta Pharmaceuticals USD 126.59M 61.87M Dec/2025
Esperion Therapeutics USD -451.36M 17.85M Sep/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
Incyte USD 5.17B 516.28M Dec/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
Ironwood Pharmaceuticals USD -264.16M 44M Sep/2025
Karyopharm Therapeutics USD -269.26M 30.33M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
PTC Therapeutics USD -205.31M 49.56M Dec/2025
Puma Biotechnology USD 115.27M 10.55M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
Sarepta Therapeutics USD 1.32B 37.26M Sep/2025
TG Therapeutics USD 607.22M 330.79M Sep/2025
Ultragenyx Pharmaceutical USD 9.16M 142.13M Sep/2025
Vertex Pharmaceuticals USD 18.67B 1.35B Dec/2025
Xencor USD 625.32M 4.96M Sep/2025